Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. - Wikidata - wikimedia - TriplyDB

Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients.

Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients.

http://www.wikidata.org/entity/Q33386883

about

Hemophagocytic lymphohistiocytosis: review of etiologies and management Clinical characteristics and treatment outcomes of autoimmune-associated hemophagocytic syndrome in adults Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis Systematic review: macrophage activation syndrome in inflammatory bowel disease Macrophage activation syndrome: advances towards understanding pathogenesis Dynamic Changes, Cut-Off Points, Sensitivity, and Specificity of Laboratory Data to Differentiate Macrophage Activation Syndrome from Active Disease.A meta-analysis of public microarray data identifies gene regulatory pathways deregulated in peripheral blood mononuclear cells from individuals with Systemic Lupus Erythematosus compared to those without Hyperferritinemia is associated with serologic antiphospholipid syndrome in SLE patients.Hematological features of pediatric systemic lupus erythematosus: suggesting management strategies in children.Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases.Clinical features and outcomes of posterior reversible encephalopathy syndrome in patients with systemic lupus erythematosus.Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features, predictive factors, and prognosis in 21 patients Macrophage Activation Syndrome.Evans Syndrome at Childhood-Onset Systemic Lupus Erythematosus Diagnosis: A Large Multicenter Study.Protein-losing enteropathy in systemic lupus erythematosus: 12 years experience from a Chinese academic center.Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice.Common variable immunodeficiency associated with hepatosplenic T-cell lymphoma mimicking juvenile systemic lupus erythematosus.High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome.Hemophagocytosis causes a consumptive anemia of inflammation.Systemic lupus erythematosus in children and adolescents.Hemophagocytic Lymphohistocytosis in the Chinese Han Population May Be Associated with an STXBP2 Gene Polymorphism.Idiopathic Hemophagocytic Lymphohistiocytosis During Pregnancy Treated with Steroids.Screening assays for primary haemophagocytic lymphohistiocytosis in children presenting with suspected macrophage activation syndrome Taxonomy for systemic lupus erythematosus with onset before adulthood Presentation of hemophagocytic lymphohistiocytosis due to a novel MUNC 13-4 mutation masked by partial therapeutic immunosuppression.Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis Unusual Association of Hemophagocytic Lymphohistiocytosis in Systemic Lupus Erythematosus: Cases Reported at Tertiary Care Center.Secondary hemophagocytic syndrome in adults: a case series of 18 patients in a single institution and a review of literature.Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment.Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis.Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review.Macrophage activation syndrome and cytokine-directed therapies.Can procalcitonin be used to distinguish between disease flare and infection in patients with systemic lupus erythematosus: a systematic literature review.Genetic defects in cytolysis in macrophage activation syndrome.Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies.Reviewing the recommendations for lupus in children.Complications of systemic juvenile idiopathic arthritis: risk factors and management recommendations.Macrophage Activation Syndrome as Onset of Systemic Lupus Erythematosus: A Case Report and a Review of the Literature.Clinical features and correct diagnosis of macrophage activation syndrome.2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Coll

P2860

Q26830538-FFAC0676-CDD4-4DC1-8295-663100562988 Q26852503-587D98F9-CF6B-4A2E-A91F-C7F0A85824CB Q27023603-C44FBC8E-2EE7-40DD-B116-DE868C72E046 Q27025349-4CDB1F5B-829C-4161-82FA-462491846CCA Q28284000-2D94EB59-9CC9-4D29-B301-6C17DC3C1651 Q30969802-CC80FF13-76B6-420E-BC49-F77CA167ABA2 Q31142463-2D3BD963-9730-4E60-90C4-2B4B5E6FFF2D Q33394453-DF8935DE-DE99-40B7-9235-354E78A105B0 Q33400710-CE3BBB88-9F5F-47E9-A6A9-9285389F5515 Q33401348-21C7A556-F81B-4DCA-9E69-826F2598EF10 Q33407827-0FE8E7FA-09F0-44F6-800D-527611705771 Q33420069-882A6917-C929-43AC-A2D0-66C36A44CDBA Q33426151-98EA983A-8C7F-4353-B78C-C8D4E5333BD0 Q33431073-C182F963-D850-4C8F-9AB5-E99275668B10 Q34663073-B85D0797-27AA-4E88-932C-8D2F04FA3DC7 Q35015661-4AD249B7-CE9C-470F-BC3A-88BD99B935BB Q35101605-CD4528DF-FF1D-49EA-82B5-141EA3090A3E Q35192858-D6CBF1C2-9EB1-4F5E-8FF5-A887676450DD Q35213574-A8174269-C84A-4BF4-B5D4-07F24414A813 Q35947491-7DCA5044-03C2-4AB2-9D71-4E6CEC85F206 Q36101367-91B82EE3-E002-49BE-866B-ED4752D856A4 Q36114616-4F7B2B17-BBB6-4914-85B6-D68958B25600 Q36287248-83FD7BD6-958A-45B5-987C-8894BC401F29 Q36295937-8AFE6149-23A5-4224-AF77-D1CA140B39C9 Q36416172-F1AA3559-9E77-44BC-8693-32FA7A5DDCC0 Q36420991-C1D3DF9B-372B-4F7F-8AB2-EAB9DCBAD7DA Q37341398-E2FB2012-2723-473D-B895-D107AC7D09FD Q37784476-31417B6C-BA43-4089-B852-BA297309B2E3 Q37993678-FFF0E014-F4CD-4A34-85B1-2ED2C06D3873 Q38064531-887E443A-E7D2-415D-BDB2-73F3AD33F283 Q38088660-CD2D2EFB-0486-467B-859A-850384374D9E Q38224085-2C25836F-986D-468A-BD87-606789D167B3 Q38234176-428A7747-FE71-4C85-A7A4-5BABE1DCA78C Q38236321-25B0234D-1CCE-4288-9DA9-91155BD0F5AB Q38267068-1ABEE257-6FC5-4913-91C1-36654CA8C354 Q38374309-C33C9261-732C-444F-8920-E684D494CD9A Q38406386-FE95E4C1-6A53-4086-812A-D1473E463F03 Q38524639-DB2CDC3A-4136-4EB2-A8FB-D37FD7AE6C14 Q38530013-6D2D1D6D-8AD6-473B-9D7D-3AE342AF6BDE Q38575277-D8F0F689-21BE-4EBE-A0A2-0B48217382FC

P2860

Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients.

http://www.wikidata.org/entity/Q33386883

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Macrophage activation syndrome ...... tudy of thirty-eight patients.

@ast

Macrophage activation syndrome ...... tudy of thirty-eight patients.

@en

type

label

Macrophage activation syndrome ...... tudy of thirty-eight patients.

@ast

Macrophage activation syndrome ...... tudy of thirty-eight patients.

@en

prefLabel

Macrophage activation syndrome ...... tudy of thirty-eight patients.

@ast

Macrophage activation syndrome ...... tudy of thirty-eight patients.

@en

P1433

Q33386883-5B222A57-D646-40F2-BA27-68137CBAB67E

P1476

Q33386883-6DEAF02D-5883-405C-9AB2-0284B0538F63

P2093

Q33386883-02754600-64F9-4F63-94A8-8DA4B510FB28

Q33386883-0EA4C033-BA49-4CEB-8A68-11E8488E4D79

Q33386883-37BE5900-6E37-40A3-83DB-2902968D734A

Q33386883-63D818F1-9FDF-4086-93EC-1964806A7671

Q33386883-694DFAF6-24EE-4851-A470-60AA7A2746E1

Q33386883-6C3985A6-ADC4-4D3A-80F9-C174890CB328

Q33386883-7441A332-6A59-4A6D-AF65-22744D905FBC

Q33386883-7DE10F8E-3B51-4A45-B27A-84E476A05A15

Q33386883-878900B7-0E96-47E9-B7FE-2B0365519030

Q33386883-9635639F-1F84-4D40-93FD-E313585E691B

P2860

Q33386883-0D2F1DF7-DCB7-44F7-B777-CB311CFACFDA

Q33386883-382F64B9-B091-4595-A698-E9CA43B82D97

Q33386883-526E3F43-CCD5-4788-92F3-6A761E498B32

Q33386883-5F4B8596-C918-4705-8062-B95CEFEF6AB2

Q33386883-68944BC6-E20E-4FF2-B246-BE11AF9AE153

Q33386883-7302351F-410C-4782-ACFE-70E166C8008E

Q33386883-7D44360A-61E8-481B-A3CB-E07CC618AAF0

Q33386883-8011091A-FC22-4E16-93EB-E7B5066449ED

Q33386883-82240664-4AF9-4F8E-806F-12E2C75F5301

Q33386883-AB474C5A-2455-401A-A41A-3CAECC9137CF

P304

Q33386883-84C3FFBF-75C0-4895-8052-4DBB59332F40

P31

Q33386883-6A18E3C3-613B-449C-AC63-7E4639DE822F

P356

Q33386883-7C37AA31-D074-4BEC-B3C8-966FA1854B89

P433

Q33386883-E48AAD7D-0E88-474D-82C3-B47D180A310B

P478

Q33386883-5E3AE06F-E290-4300-B607-53DCA0F04E28

P50

Q33386883-047E61C7-074C-45F3-B203-E32FA8570823

Q33386883-59DD9453-3D13-4188-83AD-D04643B36649

Q33386883-8B9EEE01-FD60-43F6-86BC-4A718027EE77

Q33386883-8DF8BED6-3B72-4659-8CED-5BF02B10BF5E

Q33386883-BC8DFE99-BB94-4636-B5D9-63A988E204AB

Q33386883-C46DDC48-4D96-4EC6-A4DD-38BA1ED24CF8

P577

Q33386883-2174C0D8-6F64-4A3A-8468-85016200D6DD

P5875

Q33386883-94C249F7-1029-44E3-A119-854D560DBB13

P698

Q33386883-AA6D0733-F810-45D7-B02C-A9A9B9FF5AA7

P921

Q33386883-333A1FD4-D28F-427C-B37E-88980922F35E

Q33386883-3EEA2822-40FE-4DF1-B2B6-62A2240AA0BE

P356

P1433

Arthritis & Rheumatology

P1476

Macrophage activation syndrome ...... tudy of thirty-eight patients.

@en

P2093

Alberto Fischer

http://www.w3.org/2001/XMLSchema#string

Alberto Martini

http://www.w3.org/2001/XMLSchema#string

Alejandra Beatriz Pringe

http://www.w3.org/2001/XMLSchema#string

Alessandro Parodi

http://www.w3.org/2001/XMLSchema#string

Alexei Grom

http://www.w3.org/2001/XMLSchema#string

Antonio Iglesias

http://www.w3.org/2001/XMLSchema#string

Carine Wouters

http://www.w3.org/2001/XMLSchema#string

Claudia Saad Magalhães

http://www.w3.org/2001/XMLSchema#string

Dinara Guseinova

http://www.w3.org/2001/XMLSchema#string

Dowain Wright

http://www.w3.org/2001/XMLSchema#string

P2860

Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients

Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review.

The diagnostic odds ratio: a single indicator of test performance.

HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

Relationship between damage accrual, disease flares and cumulative drug therapies in juvenile-onset systemic lupus erythematosus.

Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication?

C-reactive protein and systemic lupus erythematosus.

P304

3388-3399

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.24883

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

Claudia Bracaglia

Angela Pistorio

Raju P Khubchandani

Brigitte Bader-Meunier

Nicolino Ruperto

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38055494

http://www.w3.org/2001/XMLSchema#string

P698

19877067

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial